DK0804933T3 - Lagerstabile fibrinogenpræparater - Google Patents
Lagerstabile fibrinogenpræparaterInfo
- Publication number
- DK0804933T3 DK0804933T3 DK97106568T DK97106568T DK0804933T3 DK 0804933 T3 DK0804933 T3 DK 0804933T3 DK 97106568 T DK97106568 T DK 97106568T DK 97106568 T DK97106568 T DK 97106568T DK 0804933 T3 DK0804933 T3 DK 0804933T3
- Authority
- DK
- Denmark
- Prior art keywords
- fbg
- acid
- lyophilised
- vitamin
- pyridine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
- A61L24/10—Polypeptides; Proteins
- A61L24/106—Fibrin; Fibrinogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Surgery (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19617369A DE19617369A1 (de) | 1996-04-30 | 1996-04-30 | Lagerstabile Fibrinogen-Präparate |
Publications (2)
Publication Number | Publication Date |
---|---|
DK0804933T3 true DK0804933T3 (da) | 2004-05-17 |
DK0804933T4 DK0804933T4 (da) | 2009-06-02 |
Family
ID=7792949
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK97106568T DK0804933T4 (da) | 1996-04-30 | 1997-04-21 | Lagerstabile fibrinogenpræparater |
Country Status (8)
Country | Link |
---|---|
US (1) | US5962405A (da) |
EP (1) | EP0804933B2 (da) |
JP (1) | JP4094701B2 (da) |
AT (1) | ATE263586T1 (da) |
CA (1) | CA2203961C (da) |
DE (2) | DE19617369A1 (da) |
DK (1) | DK0804933T4 (da) |
ES (1) | ES2218615T5 (da) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AT407117B (de) * | 1997-09-19 | 2000-12-27 | Immuno Ag | Fibrinschwamm |
DE19853033A1 (de) * | 1998-11-18 | 2000-05-25 | Centeon Pharma Gmbh | Stabilisierte Proteinzubereitung für einen Gewebekleber |
US7276235B2 (en) | 1998-11-18 | 2007-10-02 | Zlb Behring Gmbh | Tissue glue with improved antiadhesive properties |
JP4889861B2 (ja) | 1998-11-18 | 2012-03-07 | ツェー・エス・エル・ベーリング・ゲー・エム・ベー・ハー | 組織接着剤のための安定化されたタンパク質調製物 |
JP4771594B2 (ja) * | 1999-02-12 | 2011-09-14 | バクスター アクチェンゲゼルシャフト | フィブリノーゲンおよびフィブロネクチンをベースとする製剤を生成するための方法ならびにこの方法により入手可能なタンパク質組成物 |
AU774118B2 (en) * | 1999-02-12 | 2004-06-17 | Baxter Healthcare Sa | A method for producing a preparation based on fibrinogen and fibronectin as well as protein compositions obtainable according to this method |
US7795218B2 (en) | 2001-04-12 | 2010-09-14 | Bioaxone Therapeutique Inc. | ADP-ribosyl transferase fusion variant proteins |
WO2003028654A2 (en) * | 2001-10-03 | 2003-04-10 | Woolverton Christopher J | Storage-stable human fibrinogen solutions |
CN1617735A (zh) * | 2001-12-04 | 2005-05-18 | 克里斯托弗·J·伍尔弗顿 | 贮存稳定性纤维蛋白密封剂 |
US7622562B2 (en) | 2002-06-26 | 2009-11-24 | Zimmer Orthobiologics, Inc. | Rapid isolation of osteoinductive protein mixtures from mammalian bone tissue |
DE10261126A1 (de) * | 2002-08-13 | 2004-03-04 | Aventis Behring Gmbh | Lagerungsstabile, flüssige Fibrinogen-Formulierung |
EP1691727B1 (en) | 2003-12-11 | 2011-07-06 | Isto Technologies Inc. | Particulate cartilage system |
US20070014780A1 (en) * | 2005-07-13 | 2007-01-18 | Statseal | Storage-stable human fibrinogen solutions |
CN1911440A (zh) * | 2005-08-08 | 2007-02-14 | 上海莱士血制品有限公司 | 一种用于形成纤维蛋白膜的试剂盒及其应用 |
EP1916964A4 (en) | 2005-08-26 | 2015-11-04 | Zimmer Inc | IMPLANTS AND METHODS FOR THE REPAIR, REPLACEMENT AND TREATMENT OF JOINT DISEASES |
US8163549B2 (en) | 2006-12-20 | 2012-04-24 | Zimmer Orthobiologics, Inc. | Method of obtaining viable small tissue particles and use for tissue repair |
JP2010516703A (ja) * | 2007-01-18 | 2010-05-20 | バクスター・インターナショナル・インコーポレイテッド | TGF−βの制御放出のためのフィブリンゲルおよびその使用 |
EP2134297B1 (en) | 2007-04-12 | 2017-03-08 | Zimmer, Inc. | Apparatus for tissue repair |
JP2010530882A (ja) | 2007-06-19 | 2010-09-16 | バクスター・インターナショナル・インコーポレイテッド | Pdgfの制御放出のためのフィブリンゲルおよびその使用 |
WO2010006219A2 (en) * | 2008-07-09 | 2010-01-14 | Baxter International Inc. | Use of scaffold comprising fibrin for delivery of stem cells |
BRPI0922524B8 (pt) | 2008-12-11 | 2021-06-22 | Baxter Healthcare Sa | estrutura semelhante a coágulo de fibrina, e, usos de uma estrutura semelhante a coágulo de fibrina, e de uma preparação de uma estrutura semelhante a coágulo de fibrina |
CA2786527A1 (en) * | 2010-01-08 | 2011-07-14 | Baxter International Inc. | Biomatrices to attract and retain regenerative and reparative cells |
CA2787883C (en) * | 2010-01-28 | 2019-02-19 | Erez Ilan | Method for improved fibrin sealing |
US9504736B2 (en) | 2010-09-23 | 2016-11-29 | The Regents Of The University Of California | Administration of serine protease inhibitors to the stomach |
KR101127127B1 (ko) * | 2011-10-27 | 2012-03-21 | 주식회사 녹십자 | 고농도 피브리노겐 용액의 제조 방법 및 이를 이용한 피브린 실란트 제품의 제조방법 |
MX351980B (es) | 2011-12-29 | 2017-11-03 | Omrix Biopharmaceuticals Ltd | Método y dispositivo para la disolucion rápida de composición sólida de proteinas solidas. |
ES2645082T3 (es) | 2012-03-12 | 2017-12-04 | The Regents Of The University Of California | Métodos y composiciones de tratamiento de heridas y reducción del riesgo de hernias incisionales |
US20140178343A1 (en) | 2012-12-21 | 2014-06-26 | Jian Q. Yao | Supports and methods for promoting integration of cartilage tissue explants |
CN110496099B (zh) | 2013-09-11 | 2022-06-21 | 伊戈尔生物药品股份有限公司 | 包含粘度降低剂的液体蛋白质制剂 |
DK3122349T3 (da) | 2014-03-25 | 2022-02-14 | Leading Biosciences Inc | Sammensætninger til behandling af autodigestion |
MX2017004306A (es) | 2014-10-01 | 2017-12-20 | Eagle Biologics Inc | Formulaciones de polisacáridos y ácido nucleico que contienen agentes de reducción de viscosidad. |
CN113908282A (zh) | 2016-01-11 | 2022-01-11 | 恒翼生物医药科技(上海)有限公司 | 用于治疗和预防粘连及肠梗阻的组合物和方法 |
CN117794516A (zh) | 2021-08-13 | 2024-03-29 | 生物测试股份公司 | 纤维蛋白原组合物和制备方法 |
AU2022426762A1 (en) | 2021-12-30 | 2024-07-04 | Baxter Healthcare Sa | Fibrinogen and thrombin solutions for a fibrin sealant and fibrin sealant kit |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AT359653B (de) * | 1979-02-15 | 1980-11-25 | Immuno Ag | Verfahren zur herstellung eines gewebekleb- stoffes |
AT359652B (de) * | 1979-02-15 | 1980-11-25 | Immuno Ag | Verfahren zur herstellung eines gewebekleb- stoffes |
AT371719B (de) * | 1980-08-25 | 1983-07-25 | Immuno Ag | Verfahren und vorrichtung zur beschleunigung des aufloesens von schwerloeslichen lyophilisierten arzneimitteln |
AT369990B (de) * | 1981-07-28 | 1983-02-25 | Immuno Ag | Verfahren zur herstellung eines gewebeklebstoffes |
DE3203775A1 (de) * | 1982-02-04 | 1983-08-11 | Behringwerke Ag, 3550 Marburg | Fibrinogenzubereitung, verfahen zu ihrer herstellungund ihre verwendung |
AT389815B (de) * | 1984-03-09 | 1990-02-12 | Immuno Ag | Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern in blutprodukten |
AT379311B (de) * | 1984-03-29 | 1985-12-27 | Immuno Ag | Vorrichtung zur applikation eines gewebeklebstoffes |
AT397203B (de) * | 1988-05-31 | 1994-02-25 | Immuno Ag | Gewebeklebstoff |
AT396548B (de) * | 1990-05-03 | 1993-10-25 | Immuno Ag | Biopsieeinrichtung |
AT402891B (de) * | 1991-06-20 | 1997-09-25 | Immuno Ag | Verfahren zur herstellung eines inaktivierten blutproduktes |
US5290918A (en) † | 1993-02-23 | 1994-03-01 | Haemacure Biotech Inc. | Process for the obtention of a biological adhesive made of concentrated coagulation factors by acidic precipitation |
US5330974A (en) * | 1993-03-01 | 1994-07-19 | Fibratek, Inc. | Therapeutic fibrinogen compositions |
-
1996
- 1996-04-30 DE DE19617369A patent/DE19617369A1/de not_active Ceased
-
1997
- 1997-04-21 ES ES97106568T patent/ES2218615T5/es not_active Expired - Lifetime
- 1997-04-21 AT AT97106568T patent/ATE263586T1/de active
- 1997-04-21 EP EP97106568A patent/EP0804933B2/de not_active Expired - Lifetime
- 1997-04-21 DK DK97106568T patent/DK0804933T4/da active
- 1997-04-21 DE DE59711487T patent/DE59711487D1/de not_active Expired - Lifetime
- 1997-04-23 US US08/838,975 patent/US5962405A/en not_active Expired - Lifetime
- 1997-04-29 CA CA002203961A patent/CA2203961C/en not_active Expired - Fee Related
- 1997-04-30 JP JP11213797A patent/JP4094701B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JP4094701B2 (ja) | 2008-06-04 |
ES2218615T3 (es) | 2004-11-16 |
EP0804933A2 (de) | 1997-11-05 |
DE19617369A1 (de) | 1997-11-06 |
CA2203961C (en) | 2008-07-08 |
ATE263586T1 (de) | 2004-04-15 |
EP0804933B2 (de) | 2009-03-11 |
CA2203961A1 (en) | 1997-10-30 |
EP0804933A3 (de) | 2000-03-22 |
JPH1036286A (ja) | 1998-02-10 |
DE59711487D1 (de) | 2004-05-13 |
DK0804933T4 (da) | 2009-06-02 |
US5962405A (en) | 1999-10-05 |
ES2218615T5 (es) | 2009-07-03 |
EP0804933B1 (de) | 2004-04-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0804933T3 (da) | Lagerstabile fibrinogenpræparater | |
Hess et al. | The coagulopathy of trauma versus disseminated intravascular coagulation | |
Stern et al. | Endothelium and regulation of coagulation | |
Fenton et al. | Thrombin and antithrombotics | |
IL96602A0 (en) | Fusion proteins and nucleic acid coding for such proteins | |
NO885109D0 (no) | Fremgangsmte og middel for forhindre blodpropp. | |
Harrington et al. | Clinical importance of thrombocytopenia occurring in the hospital phase after administration of thrombolytic therapy for acute myocardial infarction | |
ATE53299T1 (de) | Blutstillende irrigationsloesung. | |
Levi et al. | Recombinant factor VIIa as an antidote for anticoagulant treatment | |
Nesheim | Tafi | |
Potapov et al. | Activated recombinant factor VII for control of diffuse bleeding after implantation of ventricular assist device | |
ATE205091T1 (de) | Pharmazeutisches präparat enthaltend plasminogenaktivatoren | |
John et al. | Hirulog: a direct thrombin inhibitor for management of acute coronary syndromes | |
HU892304D0 (en) | Preparation and process for quick desintegration of thrombi | |
HRP950525A2 (en) | USE OF vWF CONTAINING CONCENTRATE AS COMBINATION THERAPY WIHT ANTITHROMBOTIC AND FIBRINOLYTICS | |
Becker | Thrombin antagonists and antiplatelet agents | |
Önundarson et al. | Plasminogen depletion during streptokinase treatment or two-chain urokinase incubation correlates with decreased clot lysability ex vivo and in vitro | |
Swedenborg et al. | Inactivation of thrombin by the aortic endothelium | |
Levy | Platelet inhibitors and bleeding in cardiac surgical patients | |
DE69001110D1 (de) | Thrombolytische zusammensetzung enthaltender gewebetyp, plasminogenaktivatoren oder derivate davon. | |
Eisenberg | Novel antithrombotic strategies for the treatment of coronary artery thrombosis: a critical appraisal | |
Hwang et al. | Evaluation of Coagulation Function in Hip Replacement Arthroplasty Using Thromboelastography. | |
Brozović et al. | Factor X in Freeze‐dried Factor‐VIII Reference Plasma | |
Ljungberg et al. | Potentiated thrombolysis in a Chandler system using rtPA and lys-plasminogen | |
丸山征郎 | Protein C‐Thrombomodulin System |